MetaCap

Precision BioSciences (DTIL) vs Eikon Therapeutics (EIKN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Precision BioSciences is the larger company by market cap ($282.5 million vs $256.8 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DTIL+107.28%EIKN-68.40%
+210%+64%-82%
Feb 5, 20261 yearNov 20, 2026
DTIL+94.74%EIKN-67.31%
+191%+56%-80%
Feb 2, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DTIL versus EIKN key metrics
MetricDTILEIKN
Share price$7.40$4.74
Market cap$282.46M$256.84M
1-day change+7.09%-0.42%
YTD return+77.88%—
1-year return+48.00%—
5-year return-97.23%—
P/E ratio (TTM)29.60—
EPS (TTM)$0.25$-7.86
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$34.26M—
Revenue growth (YoY)-50.12%—
Net income (latest FY)$-45.72M—
Operating margin-152.19%—
Net margin-133.45%—
52-week high$11.29$17.40
52-week low$3.53$4.72
Distance from 52-week high-34.46%-72.76%
Analyst consensusstrong_buybuy
Avg. price target upside+297.30%+406.33%
Average volume319.79K560.40K
Shares outstanding38.17M54.19M
Employees69384
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Precision BioSciences

DTIL stock →

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 69 employees

About Eikon Therapeutics

EIKN stock →

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 384 employees

DTIL vs EIKN FAQ

Which is bigger, Precision BioSciences or Eikon Therapeutics?

Precision BioSciences (DTIL) is larger, with a market capitalization of $282.46M compared with $256.84M for Eikon Therapeutics (EIKN).

Are Precision BioSciences and Eikon Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons